Overall rank by patents
#28,693
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 19 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C09K (MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE).
The verdict
Emery holds 9 US patents across 19 technology areas, rank #28,693 of 50,000 tracked assignees.
Emery Oleochemicals Gmbh has been granted 9 US utility patents between 2015 and 2022, placing Emery Oleochemicals Gmbh at rank #28,693 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in C09K (MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE). As a Foreign Corporation, Emery Oleochemicals Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Emery sits between Elwah Llc (9 patents, rank #28,689) and Encore Medical Asset Corporation (9 patents, rank #28,697) - the closest US assignees by grant volume. The composite Innovation Score of 35.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 7 in the 2015–2019 window, a -71% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Emery Oleochemicals Gmbh's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Emery Oleochemicals Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Elwah LLC
9 patents
Embalajes Capsa, S.L.
9 patents
Emerald Therapeutics, Inc.
9 patents
Emerging Compounds Treatment Technologies, Inc.
9 patents
Empow Cyber Security Ltd.
9 patents
EnE Holdings Ltd
9 patents
Encompass Vascular, Inc.
9 patents
Encore Medical Asset Corporation
9 patents
Emery Oleochemicals GmbH
9 patents
What this shows Emery holds 9 patents at rank #28,693, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,693 in granted patent volume.
Other assignees with the most granted patents in Emery's primary technology class.
Emery's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 33.3% |
| 2016 | 1 | 11.1% |
| 2017 | 1 | 11.1% |
| 2019 | 2 | 22.2% |
| 2021 | 1 | 11.1% |
| 2022 | 1 | 11.1% |
Top 15 of 19 technology areas
Overall rank by patents
#28,693
Across all tracked assignees
35.6 out of 100
How to use this portfolio
Emery's 9 grants land it in the top 49% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.